{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-22-122454","form_type":"8-K","ticker":"QURE","cik":"0001590560","company_name":"uniQure N.V.","filed_at":"2022-11-28T23:59:59+00:00","discovered_at":"2026-05-14T18:03:51.313395+00:00","generated_at":"2026-06-21T12:45:34.188408+00:00","sec_items":["1.02","8.01"],"event_type":"other_material","sentiment":"negative","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"BMS terminates collaboration with uniQure effective Feb 21, 2023","bullets":["Bristol-Myers Squibb provided termination notice for collaboration and license agreement originally dated May 2015.","Termination is effective February 21, 2023; the agreement was amended in December 2020.","BMS did not replace any of the four active Collaboration Targets during the one-year option period.","A change-of-control payment of up to $70M to BMS is still contingent; no such transaction has occurred.","The separate Investor Agreement between uniQure and BMS remains in force per its terms."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-22-122454","json":"https://secwatch.observer/filing/0001104659-22-122454.json","markdown":"https://secwatch.observer/filing/0001104659-22-122454.md","text":"https://secwatch.observer/filing/0001104659-22-122454.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1590560/000110465922122454/0001104659-22-122454-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1590560/000110465922122454/tm2231450d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-21T12:45:34.188408+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"07e956a5da08963e159a74c70b62dc8c93fa876b","claim":"uniQure N.V. terminated BMS CLA with Bristol-Myers Squibb (effective 2023-02-21).","evidence_excerpt":"On November 21, 2022, BMS provided, and the Company received, a notice that the BMS CLA, as amended, will terminate effective February 21, 2023 (the “Termination Notice”).","evidence_source":"SEC 8-K Item 1.01/1.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1590560/000110465922122454/0001104659-22-122454-index.htm","confidence":1.0,"family_label":"Material Agreements","details":[{"label":"Action","value":"termination"},{"label":"Agreement","value":"license"},{"label":"Counterparty","value":"Bristol-Myers Squibb"},{"label":"Effective","value":"2023-02-21"}],"fact_type":"material_agreement"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}